Company Overview of iCell Gene Therapeutics LLC
iCell Gene Therapeutics LLC develops Chimeric Antigen Receptor (CAR) engineered cells that target multiple types of cancer with poor prognoses and clear unmet medical need. The company creates novel CAR constructs and CAR enhancing technologies for applicability of transduced T & NK cells. iCell Gene Therapeutics LLC is based in Stony Brook, New York.
25 Health Sciences Drive
Stony Brook, NY 11790
Key Executives for iCell Gene Therapeutics LLC
iCell Gene Therapeutics LLC does not have any Key Executives recorded.
iCell Gene Therapeutics LLC Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact iCell Gene Therapeutics LLC, please visit www.icellgene.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.